← Back
Data updated: Mar 10, 2026
NESHER PHARMS
Infectious DiseaseOncologyCardiovascular
NESHER PHARMS is a generic drug manufacturer focused on Infectious Disease, Oncology, Cardiovascular. Key products include HYDROMORPHONE HYDROCHLORIDE.
1980
Since
24
Drugs
-
Trials
620
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
NYSTATIN 2026-02-05
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
DILTIAZEM HYDROCHLORIDE 2026-01-24
Labeling
DILTIAZEM HYDROCHLORIDE 2026-01-24
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 31%
1 drugs Phase 3: 1 Phase 2: 2
Oncology 31%
0 drugs Phase 3: 3 Phase 1: 2
Cardiovascular 27%
2 drugs
Dermatology 11%
0 drugs Phase 3: 1 Phase 1: 1
Pipeline Strength Pro
Loading...
Competitors Pro
Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Oncology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology, Cardiovascular
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular
Active (9)
Discontinued (15)
DILTIAZEM HYDROCHLORIDE OXYCODONE AND ACETAMINOPHEN HYDROCODONE BITARTRATE AND ACETAMINOPHEN OXYCODONE HYDROCHLORIDE POTASSIUM CHLORIDE MORPHINE SULFATE ONDANSETRON PREDNISOLONE SODIUM PHOSPHATE METOPROLOL SUCCINATE DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE PREDNISOLONE BENZONATATE MICRO-K MICRO-K 10 DISOPYRAMIDE PHOSPHATE
Company Info
- First Approval
- 1980-10-17
- Latest
- 2022-02-25
- Applications
- 33